Status:

COMPLETED

Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Spondyloarthritis

Crohn Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Spondyloarthritis and inflammatory bowel diseases are common diseases, frequently met together in overlap syndromes. Their physiopathology remains puzzling. A strong role of gut microbiota has been re...

Detailed Description

The investigators propose to conduct an exploratory study, on 10 spondyloarthritis and 20 inflammatory bowel diseases patients (10 Crohn's disease and 10 ulcerative colitis (UC), in which a first anti...

Eligibility Criteria

Inclusion

  • Patients aged over 18 years
  • Patients with the following conditions :
  • Ulcerative colitis (UC) fulfilling the ECCO criteria
  • Crohn's disease (CD) fulfilling the ECCO criteria
  • Axial or peripheral spondyloarthritis (SpA) fulfilling the Assessment of SpondyloArthritis (ASAS) criteria
  • Patients naïve to anti-TNF alpha, justifying the initiation of an anti-TNF alpha treatment according to current guidelines (ECCO Inflammatory bowel disease (IBD) recommendations, the recommendations of the French Society of Rheumatology for SpA)
  • Patients agreeing to sign the informed consent

Exclusion

  • Patient with an inflammatory disease other than UC, CD or SpA
  • History of bowel resection or digestive stoma
  • Taking antibiotics in the three months preceding the stool collection
  • Patients with contraindication to treatment
  • Pregnancy or breast feeding

Key Trial Info

Start Date :

June 5 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 16 2021

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT03359642

Start Date

June 5 2018

End Date

September 16 2021

Last Update

May 26 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Bordeaux - service d'Hépato-gastroentérologie

Pessac, France